We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

212 hedge funds and large institutions have $2B invested in Ironwood Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 70 increasing their positions, 78 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

524% more call options, than puts

Call options by funds: $8.35M | Put options by funds: $1.34M

3.89% less ownership

Funds ownership: 108.92% → 105.03% (-3.9%)

7% less funds holding

Funds holding: 227 → 212 (-15)

10% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 78

14% less capital invested

Capital invested by funds: $2.31B → $2B (-$314M)

30% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 43

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
212
Holders Change
-15
Holders Change %
-6.61%
% of All Funds
3.26%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
30
Increased
70
Reduced
78
Closed
43
Calls
$8.35M
Puts
$1.34M
Net Calls
+$7.01M
Net Calls Change
-$3.26M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$23.3M
2
Norges Bank
Norges Bank
Norway
+$15.2M
3
ECM
ExodusPoint Capital Management
New York
+$6.99M
4
RA
Royce & Associates
New York
+$5.9M
5
Renaissance Technologies
Renaissance Technologies
New York
+$5.76M

Top Sellers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
-$30.7M
2
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
-$22.2M
3
PI
Putnam Investments
Massachusetts
-$17.3M
4
UBS AM
UBS AM
Illinois
-$12.1M
5
BCM
Brown Capital Management
Maryland
-$9.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
126
Ameriprise
Minnesota
$429K -$344K -28,078 -43%
FHB
127
First Hawaiian Bank
Hawaii
$405K -$6.2K -505 -1%
MLICM
128
Metropolitan Life Insurance Company (MetLife)
New York
$402K -$47.5K -3,872 -10%
LPL Financial
129
LPL Financial
California
$402K -$45.8K -3,733 -10%
VEA
130
Virtus ETF Advisers
New York
$397K -$81.4K -6,633 -16%
BNP Paribas Financial Markets
131
BNP Paribas Financial Markets
France
$391K +$15.4K +1,256 +4%
SEI Investments
132
SEI Investments
Pennsylvania
$375K -$1.26M -102,533 -78%
AA
133
ALPS Advisors
Colorado
$363K +$7.63K +622 +2%
Janus Henderson Group
134
Janus Henderson Group
United Kingdom
$361K +$191K +15,572 +101%
Teacher Retirement System of Texas
135
Teacher Retirement System of Texas
Texas
$358K +$74.4K +6,064 +25%
Handelsbanken Fonder
136
Handelsbanken Fonder
Sweden
$338K – – –
TAM
137
Tocqueville Asset Management
New York
$333K – – –
Russell Investments Group
138
Russell Investments Group
United Kingdom
$332K -$1.31M -106,941 -79%
TRCT
139
Tower Research Capital (TRC)
New York
$328K +$46.6K +3,798 +16%
PAM
140
Panagora Asset Management
Massachusetts
$309K -$761K -62,025 -70%
Creative Planning
141
Creative Planning
Kansas
$309K – – –
AB
142
Amalgamated Bank
New York
$300K -$1.13K -92 -0.4%
PP
143
PDT Partners
New York
$299K +$315K +25,675 New
Public Employees Retirement Association of Colorado
144
Public Employees Retirement Association of Colorado
Colorado
$290K – – –
GCM
145
Graham Capital Management
Connecticut
$288K +$303K +24,724 New
ZCM
146
Zebra Capital Management
Connecticut
$274K -$106K -8,676 -27%
WAM
147
Watershed Asset Management
California
$274K +$289K +23,535 New
SFI
148
Susquehanna Fundamental Investments
Pennsylvania
$269K -$269K -21,885 -49%
ZCA
149
Zeke Capital Advisors
Pennsylvania
$265K +$21.1K +1,721 +8%
EWM
150
Evercore Wealth Management
New York
$261K – – –
4 5
6
7 8

IRWD Hedge Fund Activity: Q4 2021 in Review

212 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q4 2021, worth a combined $2B — down 14% from $2.31B a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of IRWD and 30 opened new positions — a net loss of 13 holders — while 78 trimmed existing stakes and 70 added.

The largest buyer was BlackRock, adding an estimated $23.3M. The largest seller was Camber Capital Management, cutting an estimated $30.7M.

  • 212 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q4 2021, down from 227 in Q3 2021.
  • Funds reported $2B of Ironwood Pharmaceuticals stock for Q4 2021, down 14% quarter-over-quarter.
  • 30 funds opened new Ironwood Pharmaceuticals positions in Q4 2021 and 43 closed out, a net change of -13 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q4 2021 was BlackRock, an estimated $23.3M added.
  • The largest Ironwood Pharmaceuticals seller in Q4 2021 was Camber Capital Management, an estimated $30.7M sold.

Based on aggregated 13F filings for Q4 2021.